Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 296
Ph III recruiting: 38
Growth YoY: +1.9%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 301–350 of 1,299 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07394387	Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.	recruiting	Phase 2	58	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	May 15, 2026	clinicaltrials
NCT07589699	Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP	not yet recruiting	Phase 4	59	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	0	May 15, 2026